Abstract
Parenteral amygdalin was found to be ineffective in C57BL/6 mice with B16 melanoma and in AKR mice with BW5147 lymphatic leukemia, in doses ranging from 50 to 5000 mg/kg.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Amygdalin / pharmacology
-
Amygdalin / therapeutic use*
-
Animals
-
Female
-
Leukemia, Experimental / drug therapy*
-
Leukemia, Experimental / etiology
-
Melanoma / drug therapy*
-
Melanoma / etiology
-
Melphalan / therapeutic use
-
Mice
-
Mice, Inbred AKR
-
Mice, Inbred C57BL
-
Neoplasms, Experimental / drug therapy
-
Neoplasms, Experimental / etiology
-
Nitriles / therapeutic use*
Substances
-
Nitriles
-
Amygdalin
-
Melphalan